News Conference News ESC 2025 PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy Michael O'Riordan September 01, 2025
News Conference News ESC 2025 Vericiguat Misses Mark in Stable, Well-Treated HFrEF Patients: VICTOR Michael O'Riordan August 31, 2025
News Conference News ESC 2025 Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF Michael O'Riordan August 29, 2025
News Conference News ESC 2024 ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions Michael O'Riordan September 17, 2024
News Conference News ESC 2024 ‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS Michael O'Riordan September 09, 2024
News Conference News ESC 2024 Streamlined European AF Guidelines Emphasize ‘Whole’ Patient Todd Neale September 06, 2024
News Conference News ESC 2024 Using Potassium to Prevent AF After CABG? Don’t Do That, TIGHT-K Indicates Todd Neale September 05, 2024
News Conference News ESC 2024 New ESC Guidelines on BP and Hypertension Shift Treatment Targets Lower Yael L. Maxwell September 04, 2024
News Conference News ESC 2023 ESC Cardiomyopathy Guidelines Span Range of Phenotypes Yael L. Maxwell August 31, 2023
News Conference News ESC 2022 Routine Functional Testing Unnecessary After Stenting: POST-PCI Yael L. Maxwell September 06, 2022
News Conference News ESC 2022 Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke Todd Neale August 28, 2022
News Conference News ESC 2020 Updated ESC A-fib Guidance Proposes New Path for Diagnosis, Classification, and Care Shelley Wood August 30, 2020
News Conference News ESC 2020 PARALLAX: Mixed Results for Sacubitril/Valsartan in HFpEF Todd Neale August 30, 2020
News Conference News ESC 2020 EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF Michael O'Riordan August 28, 2020
News Conference News ESC 2019 New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL Michael O'Riordan September 05, 2019
News Conference News ESC 2019 PARAGON-HF Misses Primary Endpoint, but Hints of Benefit Seen Todd Neale September 01, 2019
News Conference News ESC 2017 ESC Releases Revamped DAPT Guidance Focusing on Personalized Approach Todd Neale September 01, 2017
News Conference News ESC 2016 Long-term Exposure to Lower LDL Cholesterol, Blood Pressure Has Potential to Dramatically Cut CV Risk Todd Neale August 29, 2016
News Conference News ESC 2015 EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS Caitlin E. Cox September 02, 2015
News Conference News ESC 2012 Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients August 26, 2012